Natural Compounds
Identifiers
Titles
Observations
Resveratrol NCT04266353 Effect of Resveratrol on Serum IGF2 in African American Women Participants will be given 150 mg of resveratrol per day for six weeks
Ginseng NCT00631852 A Phase II Biomarker Trial of Gelatin Encapsulated Extract of American Ginseng Root (LEAG) in Breast Cancer American ginseng extract from the roots was administered as follows: four 250 mg tablets were taken daily for five to fourteen days prior to surgery
Artemisimin (Artesunate)
NCT00764036
Patients with metastatic or locally advanced breast cancer are being studied in a prospective open uncontrolled phase I study to determine the compatibility, safety, and pharmacokinetics of the semi-synthetic artemisinin derivative artesunate from the Chinese herb artemisia annua
The medication was given orally once day for four weeks in dosages of 100, 150, or 200 mg of artesunate.
EGCG NCT00917735 Study of the Green Tea Extract’s Efficacy on Breast Cancer Risk Biomarkers in High-Risk Women With Different Catechol-O-Methyl Transferase (COMT) Genotypes under Placebo Control Two green tea extract capsules containing 51.7% EGCG should be taken orally twice day, after breakfast and supper, for a period of one year.
Curcumin NCT03980509 Curcumin, the active ingredient in turmeric, in a ”Window Trial” for primary invasive breast cancer tumors From the time surgical resection is scheduled until the night before surgical resection, 500 mg of curcumin will be given orally twice daily, after each meal